Correction to: npj Vaccines (2024) 9:53; https://doi.org/10.1038/s41541-024-00838-8, published online 06 March 2024
In this article, the author name Núria López-Bigas was incorrectly written as Nuria López-Vigas. The original article has been corrected.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Marcos-Villar, L., Perdiguero, B., Anthiya, S. et al. Author Correction: Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA Consortium. npj Vaccines 9, 84 (2024). https://doi.org/10.1038/s41541-024-00882-4
Published:
DOI: https://doi.org/10.1038/s41541-024-00882-4
